Hendershot Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7M Buy
56,657
+1,563
+3% +$390K 1.71% 20
2025
Q4
$13.3M Buy
55,094
+7,057
+15% +$1.8M 1.69% 19
2025
Q3
$13.1M Buy
48,037
+262
+0.5% +$71.6K 1.66% 20
2025
Q2
$12.3M Buy
47,775
+945
+2% +$225K 1.65% 20
2025
Q1
$10.5M Buy
46,830
+1,374
+3% +$321K 1.43% 20
2024
Q4
$10.4M Buy
45,456
+914
+2% +$220K 1.42% 24
2024
Q3
$10.9M Buy
44,542
+234
+0.5% +$52.3K 1.48% 22
2024
Q2
$8.48M Sell
44,308
-5
-0% -$1.01K 1.22% 27
2024
Q1
$8.78M Buy
44,313
+245
+0.6% +$44.9K 1.25% 29
2023
Q4
$7.58M Buy
+44,068
New +$6.77M 1.17% 31

Other funds holding RMD

Hendershot Investments's RMD Position: Q1 2026 in Review

Hendershot Investments increased its ResMed (RMD) stake by 2.8% in Q1 2026, buying an estimated $390K and bringing the position to 56,657 shares worth $12.7M. The position accounts for 1.71% of the portfolio, ranked #20.

Hendershot Investments first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $13.3M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Hendershot Investments held 56,657 shares of ResMed worth $12.7M as of Q1 2026.
  • Hendershot Investments bought 1,563 ResMed shares in Q1 2026, an estimated $390K.
  • ResMed made up 1.71% of Hendershot Investments's portfolio in Q1 2026, its #20 holding.
  • Hendershot Investments first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
  • Hendershot Investments's ResMed position peaked at $13.3M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Hendershot Investments's 13F filing for Q1 2026, filed 27 Apr 2026.